Filing Details
- Accession Number:
- 0001179110-20-004027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-03-20 16:52:40
- Reporting Period:
- 2020-03-19
- Accepted Time:
- 2020-03-20 16:52:40
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1651561 | Tabula Rasa Healthcare Inc. | TRHC | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1219799 | Gordon Tunstall | 228 Strawbridge Drive, Suite 100 Moorestown NJ 08057 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2020-03-19 | 8,000 | $1.56 | 19,989 | No | 4 | M | Direct | |
Common Stock | Disposition | 2020-03-19 | 8,000 | $43.70 | 11,989 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Employee Stock Option (right to buy) | Disposition | 2020-03-19 | 8,000 | $0.00 | 8,000 | $1.56 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
9,288 | 2022-03-21 | No | 4 | M | Direct |
Footnotes
- The stock option vested 25% on March 21, 2013 and in equal 1/36th installments each month thereafter.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $43.69 to $43.97, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4.